Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Mar 17;303(11):1086-7.
doi: 10.1001/jama.2010.283.

Cancer's next frontier: addressing high and increasing costs

Elena B Elkin  1 , Peter B Bach
Affiliations

Cancer's next frontier: addressing high and increasing costs

Elena B Elkin et al. JAMA. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Nominal and inflation-adjusted direct medical spending attributed to cancer, 1990–2009. Direct costs are personal health care expenditures for hospital and nursing home care, drugs, home care, and physician and other professional services. Sources: 1990–1995 estimates from Brown et al.; 2000–2009 estimates are from the National Heart, Lung, and Blood Institute, based on data from multiple sources, applying the 1995 fraction of direct medical costs attributable to cancer to annual national health expenditure estimates.
See this image and copyright information in PMC

Similar articles

  • Medical care costs: how much welfare loss?
    Newhouse JP. Newhouse JP. J Econ Perspect. 1992 Summer;6(3):3-21. doi: 10.1257/jep.6.3.3. J Econ Perspect. 1992. PMID: 10128078 Review. No abstract available.
  • Is P4P really FFS?
    Wodchis WP, Ross JS, Detsky AS. Wodchis WP, et al. JAMA. 2007 Oct 17;298(15):1797-9. doi: 10.1001/jama.298.15.1797. JAMA. 2007. PMID: 17940237 No abstract available.
  • Strategies to reduce cancer-care costs.
    Goozner M. Goozner M. J Natl Cancer Inst. 2013 Feb 20;105(4):247-8. doi: 10.1093/jnci/djt020. Epub 2013 Jan 31. J Natl Cancer Inst. 2013. PMID: 23369949 No abstract available.
  • And then there were none.
    King K. King K. J Okla State Med Assoc. 2009 Sep;102(9):288-9. J Okla State Med Assoc. 2009. PMID: 19856820 No abstract available.
  • The economics of cancer care in the United States.
    Farina KL. Farina KL. Am J Manag Care. 2012 Feb;18(1 Spec No.):SP38-9. Am J Manag Care. 2012. PMID: 22468873 Review. No abstract available.
See all similar articles

Cited by

See all "Cited by" articles

References

    1. Goldman DP, Joyce GF, Lawless G, Crown WH, Willey V. Benefit design and specialty drug use. Health affairs (Project Hope) 2006;25(5):1319–1331. - PMC - PubMed
    1. USA Today/Kaiser Family Foundation/Harvard School of Public Health National Survey of Households Affected by Cancer. 2006.
    1. Neumann PJ, Palmer JA, Nadler E, Fang C, Ubel P. Cancer therapy costs influence treatment: a national survey of oncologists. Health affairs (Project Hope) 2010;29(1):196–202. - PubMed
    1. Warren JL, Yabroff KR, Meekins A, Topor M, Lamont EB, Brown ML. Evaluation of trends in the cost of initial cancer treatment. J Natl Cancer Inst. 2008;100(12):888–897. - PMC - PubMed
    1. Bach PB. Limits on Medicare's ability to control rising spending on cancer drugs. N Engl J Med. 2009;360(6):626–633. - PubMed